Verified ProfileEN

SinoMed Peptide Valley Co., Ltd.

Order verification — $199

Manufacturing · Other Food Manufacturing

Verification dossier

SinoMed Peptide Valley Co., Ltd. is a Chinese company based in Jilin. The company operates in the other food manufacturing sector, within the broader manufacturing industry. Established 2017, the company has been operating for 9 years.

Sinolinks tracks SinoMed Peptide Valley Co., Ltd. as part of our independent verification practice. The full 18-section verification report covers ownership, financial standing, regulatory standing, trade relationships, and operating credentials — reviewed by our Hong Kong-based expert and delivered in 24 hours.

Business scope

Licensed items: Food production; food sales; cosmetic production; health food production; beverage production; alcoholic beverage production; alcohol sales; aquaculture; production of Class II medical devices; production of Class III medical devices; sales of Class III medical devices; production of formula foods for special medical purposes; production of processed grain foods; import and export of pharmaceuticals; production of pharmaceutical excipients. General items: Food sales (pre-packaged food only); wholesale of cosmetics; retail of cosmetics; online sales (excluding goods requiring licensing); sales of health food (pre-packaged); wholesale of aquatic products; retail of aquatic products; cultivation of Chinese herbal medicine; technical services.

Independent verification

Order the full verified report on this company

An 18-section verification report on this Chinese company, expert-reviewed and delivered in English within 24 hours. We support clients in six languages. HK-entity invoicing.

Order verification — $199

Independent verification

Included in the full report

Full Chinese legal name

Registration identifier

Legal representative & senior officers

Beneficial ownership & equity history

Registered address & operating premises

Capital & recent annual filings

Verified contact channels

Branches, controlled entities & investments

Trademark & patent portfolio

Trade relationships

Regulatory standing review